Cargando…
Updates to the antitumor mechanism of oncolytic virus
Oncolytic viruses (OVs) are promising new therapeutic agents in the field of malignant tumor treatment. OVs can achieve the goal of targeted therapy by selectively killing tumor cells and inducing specific antitumor immunity. The key roles of OVs are tumor targeting and tumor killing mechanisms. Rec...
Autores principales: | Bai, Yang, Hui, Peng, Du, Xiaoyu, Su, Xing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6501037/ https://www.ncbi.nlm.nih.gov/pubmed/30900824 http://dx.doi.org/10.1111/1759-7714.13043 |
Ejemplares similares
-
Win or loss? Combination therapy does improve the oncolytic virus therapy to pancreatic cancer
por: Luo, Wenhao, et al.
Publicado: (2022) -
Aptamers Enhance Oncolytic Viruses’ Antitumor Efficacy
por: Dymova, Maya A., et al.
Publicado: (2022) -
Current strategies in engaging oncolytic viruses with antitumor immunity
por: Boagni, Drew Ashton, et al.
Publicado: (2021) -
An update on the development of antiviral against Mayaro virus: from molecules to potential viral targets
por: Paschoalino, Marina, et al.
Publicado: (2023) -
Reporter Transgenes for Monitoring the Antitumor Efficacy of Recombinant Oncolytic Viruses
por: Semenova, A. V., et al.
Publicado: (2022)